Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)". This grant aims to support research projects that utilize advanced cancer biology methods and model systems to study the effects of different types of radiation used in radionuclide-based therapeutics on normal tissue, tumor cells, and the tumor microenvironment. The funding instrument for this opportunity is a grant, and it falls under the category of funding activity related to health. The grant does not require cost sharing or matching. The maximum award ceiling for this grant is $500,000. Eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The closing date for applications is May 7, 2025. For more information and to apply, please visit the following link: [Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-22-139.html). For any inquiries, please contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)". This grant aims to support exploratory research projects focused on the development and validation of emerging technologies that improve the quality of samples used for cancer research or clinical care.
The grant seeks to address issues related to the degradation of targeted analytes during the collection, processing, handling, and storage of cancer-relevant biospecimens. It specifically solicits R33 applications that have overcome major feasibility gaps for the technology or methodology, demonstrated with supportive preliminary data, but still require further development and rigorous validation.
The goal of this grant is to develop highly innovative technologies that maximize the quality and utility of biological samples used for downstream analyses. It aims to support the development of tools, devices, instrumentation, and associated methods that preserve or protect sample integrity, establish verification criteria for quality assessment and control, and handle samples under diverse conditions.
These technologies are expected to accelerate and enhance research in cancer biology, early detection and screening, clinical diagnosis, treatment, epidemiology, and address issues associated with cancer health disparities. By reducing pre-analytical variations that affect biospecimen sample quality, the grant aims to improve the overall quality of cancer research and clinical care.
The grant does not require cost sharing or matching requirements and is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments, non-domestic entities, regional organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territories or Possessions.
The closing date for applications is October 1, 2024, and the maximum award ceiling is $300,000. For more information and to apply, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-011.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-011.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
Long-Term Effects of Disasters on Healthcare Systems in Populations with Health Disparities (R01- Clinical Trial Optional) National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Long-Term Effects of Disasters on Healthcare Systems in Populations with Health Disparities (R01- Clinical Trial Optional)". This grant aims to support collaborative research focused on understanding the long-term effects of natural and/or human-made disasters on health care systems serving populations that experience health disparities living in the U.S. and its territories. The grant does not require cost sharing or matching requirements and falls under the category of Health. The maximum award ceiling for this grant is $500,000. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities, Indian/Native American Tribal Governments, Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities, U.S. Territory or Possession. However, non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply. The closing date for this grant opportunity is May 7, 2027. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-24-109.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-109.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)". This grant aims to support novel environmental health research that involves collecting human biological samples or environmental exposure data within a limited window of opportunity. The research should focus on understanding the consequences of natural and human-made disasters, emerging environmental public health threats, and policy changes in the U.S. and abroad. The funding is intended for projects that require rapid review and funding, with a shorter timeline than the typical NIH grant review/award cycle. The grant does not require cost sharing or matching. The maximum award ceiling is $275,000. Other eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities, Indian/Native American Tribal Governments, non-domestic entities, regional organizations, Tribally Controlled Colleges and Universities, and U.S. Territories or Possessions. The closing date for applications is December 1, 2025. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-23-011.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-23-011.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed) National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)". This grant aims to support pre-clinical research projects that utilize advanced cancer biology methods and model systems to study the effects of radiopharmaceutical therapy (RPT) agents on normal tissue, tumor cells, and the tumor microenvironment. The goal is to understand how RPT dynamically impacts cancer biology processes, which can inform the development of new targeting strategies and approaches for clinical trials. The grant does not require cost sharing or matching and falls under the category of funding activity for health. The opportunity is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The closing date for applications is May 7, 2025. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-140.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-140.html). For any inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.